RayzeBio (NASDAQ: RYZB) to Resume Trading at 7:30 a.m. Bristol Myers Squibb (NYSE: BMY) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trading Halts

Karuna Therapeutics cut by analysts following news of Bristol-Myers Squibb acquisitionDecember 26, 2023 11:14 AM Bristol-Myers Squibb (BMY) to buy RayzeBio (RYZB) for $4.1 billionDecember 26, 2023 7:56 AM Bristol-Myers Squibb (BMY) Announces Acquisition of RayzeBio (RYZB) for $62.50 Per Share, $4.1 BillionDecember 26, 2023 7:00 AM  Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBioDecember 26, 2023 6:59 AM RayzeBio (RYZB) Halted, News PendingDecember 26, 2023 6:56 AM